18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia



Status:Available
Conditions:Endocrine
Therapuetic Areas:Endocrinology
Healthy:No
Age Range:Any
Updated:3/22/2019
Contact:Susan Becker, RN, BSN, CCRC
Email:Beckers@email.chop.edu
Phone:267-426-0269

Use our guide to learn which trials are right for you!

Expanded Access Use of 18F-L-Fluoro-DOPA PET/CT Scan Localization of Focal Pancreatic Lesions in Subjects With Hyperinsulinemic Hypoglycemia

This purpose of this study is to determine the ability of an
18F-fluoro-L-dihydroxyphenylalanine (18F-DOPA) PET scan to detect a focal lesion of
hyperinsulinism and determine the location in patients with congenital hyperinsulinism,
Beckwith Wiedemann Syndrome and suspected insulinoma. Safety data will be collected.


Inclusion Criteria:

- Subjects of any age with hyperinsulinemic hypoglycemia, diagnosed by a fasting test
and/or response to glucagon stimulation.

- Subjects who are eligible for pancreatic surgery regardless of prior pancreatic
surgery

Exclusion Criteria:

- Pregnant or lactating females

- Any other major illness or condition that in the investigator's judgment will
substantially increase the risk associated with the subject's participation in this
study

- Subjects who are not a candidate for pancreatic surgery
We found this trial at
1
site
South 34th Street
Philadelphia, Pennsylvania 19104
 215-590-1000
Principal Investigator: Lisa States, MD
Children's Hospital of Philadelphia Since its start in 1855 as the nation's first hospital devoted...
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials